Long-term Survival and Late Toxicity after Chemoradiotherapy for Cervical Cancer - The Addenbrooke's Experience

Clinical Oncology

Volumn 20, Issue 5, 2008, Pages 358-364

  Tan, L T ^a   Zahra, M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cervical carcinoma; chemoradiotherapy; late toxicity; local control; survival

Indexed keywords

CISPLATIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; AVASCULAR NECROSIS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; COLON RESECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; DIARRHEA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEMATURIA; HUMAN; ILEUS; MAJOR CLINICAL STUDY; METASTASIS; MOTOR NEUROPATHY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECURRENT CANCER; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SALVAGE THERAPY; SENSORY NEUROPATHY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; URINARY FREQUENCY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EROSION;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MIDDLE AGED; PLATINUM COMPOUNDS; RADIOTHERAPY; SURVIVAL ANALYSIS; UTERINE CERVICAL NEOPLASMS;

EID: 43049176647     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.03.001     Document Type: Article

References (24)

1. Green J., Kirwan J., Tierney J., et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix. Cochrane Database Syst Rev 3 (2005) CD002225
2. Lukka H., Hirte H., Fyles A., et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer-a meta-analysis. Clin Oncol (R Coll Radiol) 14 3 (2002) 203-212
3. Kirwan J.M., Symonds P., Green J.A., Tierney J., Collingwood M., and Williams C.J. A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol 68 3 (2003) 217-226
4. Tan L.T., Russell S., and Burgess L. Acute toxicity of chemo-radiotherapy for cervical cancer: the Addenbrooke's experience. Clin Oncol (R Coll Radiol) 16 4 (2004) 255-260
5. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 9077 (1997) 535-540
6. Rose P.G., Ali S., Watkins E., et al. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study. J Clin Oncol 25 19 (2007) 2804-2810
7. Eifel P.J., Moughan J., Erickson B., Iarocci T., Grant D., and Owen J. Patterns of radiotherapy practice for patients with carcinoma of the uterine cervix: a patterns of care study. Int J Radiat Oncol Biol Phys 60 4 (2004) 1144-1153
8. International Federation of Gynecology and Obstetrics (FIGO). 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 Suppl 1 (2006) S43-S103
9. King M., McConkey C., Latief T.N., Hartley A., and Fernando I. Improved survival after concurrent weekly cisplatin and radiotherapy for cervical carcinoma with assessment of acute and late side-effects. Clin Oncol (R Coll Radiol) 18 1 (2006) 38-45
10. Chen S.W., Liang J.A., Hung Y.C., et al. Concurrent weekly cisplatin plus external beam radiotherapy and high-dose rate brachytherapy for advanced cervical cancer: a control cohort comparison with radiation alone on treatment outcome and complications. Int J Radiat Oncol Biol Phys 66 5 (2006) 1370-1377
11. Novetsky A.P., Einstein M.H., Goldberg G.L., et al. Efficacy and toxicity of concomitant cisplatin with external beam pelvic radiotherapy and two high-dose-rate brachytherapy insertions for the treatment of locally advanced cervical cancer. Gynecol Oncol 105 3 (2007) 635-640
12. Perez C.A., Fox S., Lockett M.A., et al. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods. Int J Radiat Oncol Biol Phys 21 4 (1991) 885-898
13. Tan L.T., Jones B., Gee A., and Kingston R.E. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique. Br J Radiol 70 840 (1997) 1259-1269
14. Khoury G.G., Bulman A.S., and Joslin C.A. Long term results of Cathetron high dose rate intracavitary radiotherapy in the treatment of carcinoma of the cervix. Br J Radiol 64 767 (1991) 1036-1043
15. Newman G. Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix. Radiother Oncol 39 2 (1996) 97-103
16. Crook J.M., Esche B.A., Chaplain G., Isturiz J., Sentenac I., and Horiot J.C. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 8 4 (1987) 321-332
17. Perez C.A., Camel H.M., Kuske R.R., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol 23 2 (1986) 127-140
18. Dhadda A.S., and Chan S. Bilateral avascular necrosis of the hips after chemoradiotherapy for cervical cancer. Clin Oncol (R Coll Radiol) 18 7 (2006) 576-577
19. Potter R., Knocke T.H., Fellner C., Baldass M., Reinthaller A., and Kucera H. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 4 2 (2000) 159-172
20. Potter R., Dimopoulos J., Georg P., et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83 2 (2007) 148-155
21. Micha J.P., Goldstein B.H., Rettenmaier M.A., Brown III J.V., John C.R., and Markman M. Surgery alone or surgery with a combination radiation or chemoradiation for management of patients with bulky-stage IB2 cervical carcinoma. Int J Gynecol Cancer 16 3 (2006) 1147-1151
22. Havrilesky L.J., Leath C.A., Huh W., et al. Radical hysterectomy and pelvic lymphadenectomy for stage IB2 cervical cancer. Gynecol Oncol 93 2 (2004) 429-434
23. Tan L.T., and Zahra M. Predictors of radiation response in cervix cancer. In: Varaj H.T. (Ed). Trends in cervical cancer research (2007), Nova Science Publishers, Hauppauge NY 149-165
24. Eifel P.J., Burke T.W., Morris M., and Smith T.L. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol Oncol 59 1 (1995) 38-44